Abraxis BioScience Names CFO

Los Angeles-based Abraxis BioScience said today that it has named David O'Toole as the firm's Executive Vice President and Chief Financial Officer. O'Toole joins the firm from Deloitte & Touche LLP, where he was a Partner in the firm's Strategic Client Group. O'Toole has served at Deloitte for the past 16 years. Abraxis said that it's current CFO, Lisa Gopala, has resigned to join a philanthropic venture fund. Abraxis BioScience is a biopharmaceuticals development firm.